Continuous infusion chemotherapy, radiotherapy, and FDG‐PET are feasible during extracorporeal membrane oxygenation

Extracorporeal membrane oxygenation (ECMO) may be used in extreme circumstances for patients with a mediastinal mass and respiratory failure. We report on a young man with primary mediastinal B‐cell lymphoma invading into the trachea, requiring a 40‐day ECMO run who underwent fluorodeoxyglucose positron emission tomography (FDG‐PET) imaging and treatment with concurrent mediastinal irradiation and continuous infusion chemotherapy while on this life‐saving technology. This case illustrates that oncology patients may be managed by multidisciplinary teams for extended periods in extraordinary circumstances using multimodality therapies. Additionally, to our knowledge this is the first case to demonstrate the feasibility of FDG‐PET imaging while on ECMO.